Requirements of a Project Manager

David Hanlon is a stellar leader who has many years of experience as a project manager in the pharmaceutical field. He has overseen the development of new products and managed technology transfers. Project managers are extremely important to the success of any pharmaceutical manufacturing operation.

The competitive nature of the industry makes it imperative for a pharmaceutical or biotechnology company to place successful products on the marketplace. Putting a knowledgeable project manager at the helm of the operation is an integral part of that strategy. There are many challenges involved in creating new pharmaceuticals or other medical products. The drug development processes can incur many pitfalls from development delays, planning problems, unforeseen mistakes, cost overruns, and losses due to high turnover.

Many shortcomings in the launch process can be avoided with a good project manager at the helm. A product manager differs from a general manager in that they only deal with the operation and running of the company, as well as manufacturing, marketing, sales, human resources, and financial planning.

A project is temporary and organized to achieve a certain objective or goal, with teams assigned for that particular project and strict deadlines in place. Project managers are needed to manage clinical trials, implement marketing programs, launch blockbuster drugs, run sales meetings, and in the development process.

David Hanlon is involved in every capacity of the product launch and pays great attention to detail and makes sure that the job runs smoothly. He holds a strong work ethic and believes in following each project until completion, assuring that there are no loose ends.

​

 

David Hanlon – Trends in Pharmaceutical Products

David Hanlon is one of the leading professionals in the pharmaceutical industry. In his current position he oversees the integration of a 1 billion dollar endo-vascular and cardio-vascular device business. Part of his job is to stay on the forefront of the pharmaceutical industry. In 2015, there are a few trends setting the tone for “big pharmas” future. Many of these innovations come in the wake of rising healthcare and poor patient follow-up.

Personalized health distributed and tracked in a smart phone society. Apple released its iHealth app for the iPhone, which is a toolbox for healthcare technology companies to create their own health-based apps. The new Apple app should start to take off this year, and lead to a steady stream of competing apps at the iTunes app store.

The dramatic annual growth in global healthcare spending is forcing governments to find ways to bring rising healthcare costs down. New innovations and technology are one way that costs are being kept down. Many of these innovations will involve giving patients hi-tech, wearable devices and apps, which can help doctors stay in better contact with patients and on a more regular basis.

David Hanlon serves as a both a leader and a manager within his current role at Cardinal Health. He has also overseen the design of new facilities that manufacture Pharmaceutical products such as creams, liquids, ointments, sterile needles, tablets, as well as medical device products. Through his efforts, the company has seen much success.

​

 

David Hanlon – Fuse by Cardinal Health

Presently David Hanlon is the Senior Vice President of Quality and Regulatory Affairs for Medical Devices at Cardinal Health.  The $103 billion healthcare services company is headquartered in Dublin, Ohio, and is works to improve the cost-effectiveness of health care. Cardinal Health allows hospitals, pharmacies, ambulatory surgery centers, laboratories and physician offices to reduce costs and improve the quality of care by being able to focus on patient care instead.

Cardinal Health opened Fuse, an innovative lab focused on improving the future of the health industry. The lab focuses on ways to reduce healthcare complexity and expense by optimizing operations. Fuse also makes the clinical data side of operations more streamlined so that each patient can get the right treatments in a timely manner.

Cardinal Health is an important link in the health care supply chain, providing medical products, pharmaceuticals and services to more than 100,000 locations every day.  It’s also leading the industry in direct-to-home medical supplies distribution. The company is a leading manufacturer of surgical products such as surgical apparel, gloves, and fluid management products. Cardinal Health is ranked #26 on the Fortune 500 and operates the largest network of radio pharmacies in the nation, each one dispensing life saving early diagnosis products.

David Hanlon has held other top positions in the healthcare industry such as Vice President for Wyeth, which is now part of Pfizer and Fisher Diagnostics. He oversees a group of highly-trained personnel in areas including product management, relationship building, strategizing company’s growth, upholding strong ethics and overseeing product launch.